LOXL2 and hepatocellular carcinoma: Given that ECM modification could be modulated by various factors and HCC patients have different disease backgrounds, it remains a challenge to study the causal relationship between HBx expression, HIF-1α, LOXL2, and collagen crosslinking in clinical specimens.